Haemorrhagic stroke is a life-threatening emergency that demands immediate action and specialized care. When a blood vessel in the brain ruptures and bleeds, every second becomes critical, not just for survival but for preserving brain function and quality of life afterward.

Understanding Treatment Goals and Approaches

When a haemorrhagic stroke occurs, treatment aims to do several important things at once. The first and most urgent goal is to stop the bleeding inside or around the brain. Once the bleeding is controlled, doctors work to reduce the dangerous pressure that builds up inside the skull, which can damage brain cells even further. Beyond these immediate concerns, treatment focuses on preventing complications, protecting remaining brain tissue, and supporting the person’s recovery journey.^[1][4]

The approach to treating haemorrhagic stroke depends on many factors. Where exactly the bleeding happened matters tremendously—whether it’s deep inside the brain tissue (called intracerebral haemorrhage) or in the space between the brain and its protective covering (called subarachnoid haemorrhage). The size of the bleed, what caused it, the person’s age and overall health, and how quickly treatment begins all influence which therapies doctors will use.^[3][6]

Treatment typically happens in phases. Emergency care comes first, focusing on stabilizing the person and stopping further damage. Then comes acute medical management in a hospital setting, often in specialized stroke units. After the immediate danger passes, rehabilitation becomes the focus, helping people regain lost abilities and adjust to any lasting changes. Throughout all these phases, preventing another stroke remains a constant concern.^[9][11]

Standard Treatment Approaches

When someone arrives at the hospital with a suspected haemorrhagic stroke, doctors act quickly to stabilize vital functions. This means ensuring the person can breathe properly, maintaining adequate oxygen levels, and supporting blood circulation. If consciousness is severely impaired, doctors may need to insert a breathing tube to protect the airway and ensure the brain receives enough oxygen.^[11][13]

Blood Pressure Management

Controlling blood pressure is one of the most crucial aspects of treating haemorrhagic stroke. High blood pressure can make bleeding worse, yet lowering it too much could reduce blood flow to the brain. Doctors carefully balance these risks by using medications to bring blood pressure down to safer levels—typically aiming for specific targets based on each person’s situation. Common blood pressure medications used include beta-blockers, which slow the heart rate and reduce the force of heartbeats; calcium channel blockers, which relax blood vessel walls; and ACE inhibitors or ARBs, which work through hormone systems to lower pressure.^[11][15]

Hemostatic Therapy

Hemostatic therapy aims to stop bleeding and prevent it from worsening. If someone was taking blood-thinning medications (anticoagulants) before the stroke, doctors must reverse these effects quickly. Different blood thinners require different reversal agents. For warfarin, doctors give vitamin K along with fresh frozen plasma or prothrombin complex concentrates, which contain clotting factors the body needs. Specialized antidotes exist for newer blood thinners as well.^[11][15]

Studies have explored whether giving clotting medications to people who weren’t on blood thinners might help. Recombinant factor VIIa, a laboratory-made clotting protein, showed promise in early research by reducing bleeding growth. However, larger studies revealed disappointing results—while it did limit bleeding expansion, it didn’t improve long-term outcomes and carried risks of blood clots forming elsewhere in the body.^[11]

Managing Brain Pressure

When blood leaks into the confined space of the skull, it creates dangerous pressure on the brain. To reduce this intracranial pressure, doctors use several approaches. Mannitol, an osmotic diuretic, draws fluid out of brain tissue and into the bloodstream, where kidneys can eliminate it. This medication works relatively quickly but must be used carefully to avoid dehydration or electrolyte imbalances. Another approach involves having patients breathe faster (hyperventilation), which temporarily lowers brain pressure through changes in blood vessel size, though this effect doesn’t last long.^[11][13]

Seizure Prevention and Treatment

Seizures can occur after haemorrhagic stroke, particularly in the first few days. Between 4 and 28 percent of people with brain bleeding experience seizures, and some of these seizures don’t produce obvious shaking movements, making them harder to detect. When clinical seizures happen or when brain wave monitoring shows seizure activity affecting mental status, doctors treat them with antiepileptic medications. Lorazepam or diazepam, both benzodiazepines, work quickly to stop ongoing seizures. For longer-term seizure control, doctors traditionally used phenytoin or fosphenytoin, though increasingly they prescribe levetiracetam, which appears equally effective with fewer side effects.^[11]

Whether to give antiseizure medications to prevent seizures in people who haven’t had one remains controversial. Some evidence suggests prophylactic antiepileptic drugs might actually worsen outcomes, so current guidelines generally recommend using them only when seizures have occurred.^[11]

Surgical Interventions

Surgery plays an important role in treating certain haemorrhagic strokes, though not everyone needs an operation. When bleeding is large or in a location causing severe pressure, removing the accumulated blood through surgery can be lifesaving. Craniotomy, where surgeons open the skull to access and remove the blood clot, is one option. This traditional approach works well for accessible bleeds, though it’s major surgery requiring general anesthesia and recovery time.^[14][15]

For bleeds caused by a ruptured aneurysm—a weak, bulging spot on a blood vessel—doctors have two main repair options. Surgical clipping involves placing a tiny metal clip at the aneurysm’s base to stop blood from flowing into it, preventing further bleeding. This requires opening the skull but provides a permanent solution. Alternatively, endovascular coiling uses a catheter threaded through blood vessels to the aneurysm, where tiny platinum coils are released to fill and seal it off from the inside. This less invasive approach works through small incisions but isn’t suitable for all aneurysm shapes and locations.^[14][15]

When bleeding comes from an arteriovenous malformation (AVM)—an abnormal tangle of blood vessels—surgeons may remove it entirely if it’s accessible and not too large. For deeper or larger AVMs, removal might cause too much damage to healthy brain tissue, making surgery too risky. In such cases, doctors may use stereotactic radiosurgery, which focuses multiple radiation beams on the AVM to gradually seal it closed over months or years.^[4][14]

Duration and Recovery

The acute treatment phase typically lasts days to weeks, depending on the severity of the stroke and whether complications arise. People usually spend time in an intensive care unit for close monitoring, then transition to a regular hospital room or rehabilitation facility. Blood pressure medications often continue indefinitely, as controlling hypertension remains essential for preventing future strokes.^[6][9]

Side Effects and Complications

Standard treatments carry various risks. Blood pressure medications can cause dizziness, fatigue, or electrolyte imbalances if they lower pressure too much. Medications to reverse blood thinners can increase clotting risks elsewhere in the body. Surgery carries risks of infection, additional bleeding, brain swelling, or damage to surrounding brain tissue. Seizure medications can cause drowsiness, coordination problems, or thinking difficulties. Doctors carefully weigh these risks against potential benefits for each person.^[11][13]

Treatment in Clinical Trials

While standard treatments have improved outcomes for haemorrhagic stroke, researchers continue searching for better approaches. Clinical trials test new medications, surgical techniques, and strategies for minimizing brain damage and improving recovery. These studies happen in phases, each designed to answer specific questions about safety and effectiveness.

Understanding Clinical Trial Phases

Phase I trials focus on safety. Researchers give small doses of a new treatment to a small number of people to see if it causes harmful effects and to understand how the body processes it. These early studies help determine safe dose ranges before larger testing begins.

Phase II trials examine whether a treatment actually works. These studies involve more participants and look at whether the treatment produces the desired biological effects—for example, whether a medication reduces bleeding growth or improves brain swelling. Researchers carefully measure these effects and continue monitoring for side effects.

Phase III trials compare new treatments against standard care in large groups of people. These studies definitively determine whether a new approach works better than existing options and whether benefits outweigh risks. Only treatments proving superior or equally effective with fewer side effects typically gain approval for general use.

Phase IV trials continue after a treatment enters standard practice, monitoring long-term effects and rare complications that might not appear in smaller studies.^[11]

Early Bleeding Removal Techniques

Researchers are investigating whether removing blood from the brain earlier and through less invasive methods might improve outcomes. Traditional surgery requires opening the skull, but newer approaches use small instruments and cameras inserted through tiny holes. Minimally invasive endoscopic surgery allows surgeons to remove blood clots using specialized tools guided by imaging. Early studies suggest this approach might reduce complications compared to traditional craniotomy, though researchers are still determining which patients benefit most and the optimal timing for intervention.^[11]

Intensive Blood Pressure Reduction

The INTERACT (Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial) studies examined whether lowering blood pressure more aggressively than standard protocols help. Combined analysis of INTERACT 1 and 2 trials suggested that intensive blood pressure reduction early after haemorrhagic stroke lessens the absolute growth of blood clots. This effect appeared especially pronounced in people who had been taking blood-thinning medications before their stroke. These findings have influenced treatment guidelines, though doctors still individualize blood pressure targets based on each person’s circumstances.^[11]

Novel Hemostatic Approaches

Beyond recombinant factor VIIa, researchers have explored other ways to stop bleeding and prevent its expansion. Some studies investigate whether giving specific clotting factors or platelets might help, even in people not on blood thinners. Others examine medications that strengthen blood vessel walls or reduce inflammation around bleeding sites. These approaches remain experimental, with ongoing trials assessing their safety and potential benefits.

Neuroprotective Strategies

Even after bleeding stops, brain cells continue dying from swelling, inflammation, and chemical changes triggered by blood in the brain tissue. Neuroprotective therapies aim to protect brain cells from this secondary damage. Researchers are testing various approaches, including medications that reduce inflammation, antioxidants that counter harmful chemical reactions, and drugs that stabilize brain cell membranes. Some trials examine whether cooling the brain (therapeutic hypothermia) might reduce damage, similar to approaches used after cardiac arrest. While promising in laboratory studies, translating these benefits to human patients has proven challenging.^[19]

Stem Cell and Regenerative Therapies

Looking beyond preventing damage, some researchers explore whether the brain might be helped to repair itself. Stem cell therapies involve introducing cells capable of developing into various brain cell types. The hope is these cells might replace damaged neurons, support surviving cells, or release factors that promote healing. Early-phase human trials are examining safety and feasibility, with researchers tracking whether introduced cells survive, integrate into brain tissue, and produce functional improvements. These studies remain in very early stages, with much to learn about optimal cell types, delivery methods, and timing.

Advanced Imaging-Guided Treatments

Better imaging technology allows doctors to visualize bleeding and brain damage with increasing detail. Clinical trials are testing whether using advanced imaging techniques to guide treatment decisions improves outcomes. For example, some studies use specialized MRI sequences to identify areas of brain tissue at risk but potentially savable, helping doctors decide who might benefit from aggressive interventions. Others use imaging to predict which blood clots might expand, targeting intensive treatment to those at highest risk.

Eligibility and Locations

Clinical trial eligibility varies by study. Typically, trials enroll people within specific time windows after stroke onset—often within hours or days for acute treatment studies. Age, stroke severity, bleeding size and location, and other medical conditions affect eligibility. Many trials operate at specialized stroke centers in multiple countries, including locations in the United States, Europe, and increasingly worldwide. People interested in participating should discuss options with their stroke care team, who can identify appropriate nearby trials.

Most common treatment methods

• Blood pressure control medications
  • Beta-blockers that slow heart rate and reduce the force of contractions
  • Calcium channel blockers that relax blood vessel walls
  • ACE inhibitors and ARBs that work through hormonal pathways to lower pressure
  • Careful monitoring to balance reducing bleeding risk while maintaining adequate brain blood flow
• Hemostatic therapy
  • Vitamin K and prothrombin complex concentrates to reverse warfarin effects
  • Specialized antidotes for newer blood-thinning medications
  • Fresh frozen plasma to provide missing clotting factors
  • Experimental use of recombinant factor VIIa in research settings
• Intracranial pressure management
  • Mannitol or other osmotic diuretics to draw fluid from brain tissue
  • Controlled hyperventilation for temporary pressure reduction
  • Head positioning and careful fluid management
  • Surgical decompression when medical management proves insufficient
• Seizure management
  • Benzodiazepines (lorazepam, diazepam) for acute seizure control
  • Levetiracetam for longer-term prevention with fewer side effects
  • Traditional antiepileptics (phenytoin, fosphenytoin) when appropriate
  • Continuous brain wave monitoring to detect non-obvious seizures
• Surgical interventions
  • Craniotomy for removing large, accessible blood clots
  • Surgical clipping to seal ruptured aneurysms permanently
  • Endovascular coiling as a less invasive aneurysm treatment
  • AVM removal when location and size permit safe surgery
  • Minimally invasive endoscopic approaches being studied in trials
• Radiation therapy
  • Stereotactic radiosurgery to gradually seal arteriovenous malformations
  • Focused radiation beams targeting abnormal blood vessel tangles
  • Gradual closure occurring over months to years following treatment
• Supportive care
  • Airway protection and mechanical ventilation when consciousness impaired
  • Blood glucose monitoring and maintenance of normal levels
  • Infection prevention with gastric ulcer prophylaxis
  • Careful fluid and electrolyte management
• Rehabilitation therapies
  • Physical therapy to improve mobility, strength, and independence
  • Occupational therapy for relearning daily living activities
  • Speech therapy to restore communication and swallowing abilities
  • Cognitive rehabilitation to address memory, problem-solving, and organizational skills
  • Psychological support for managing stress, anxiety, and emotional changes